Asymmetric dimethylarginine (ADMA):: a key regulator of nitric oxide synthase

被引：83
|
作者：
Böger, RH
Vallance, P
Cooke, JP
机构：
[1] Univ Hamburg, Hosp Eppendorf, Ctr Med Expt, Inst Expt & Clin Pharmacol,Clin Pharmacol Unit, D-20246 Hamburg, Germany
[2] UCL, Dept Med, Ctr Clin Pharmacol & Therapeut, London WC1E 6JJ, England
[3] Stanford Univ, Sch Med, Falk Cardiovasc Res Ctr, Program Vasc Med & Biol, Stanford, CA 94305 USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2003年 / 4卷 / 04期
关键词：
D O I：
10.1016/S1567-5688(03)00027-8
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [31] Asymmetric dimethylarginine (ADMA):: an endogenous inhibitor of NO synthase -: also a risk marker for preeclampsia?
    Maas, R.
    Baschat, A.
    Hecher, K.
    Boeger, R. H.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (06) : 611 - +
  • [32] Urinary Dimethylamine (DMA) and Its Precursor Asymmetric Dimethylarginine (ADMA) in Clinical Medicine, in the Context of Nitric Oxide (NO) and Beyond
    Tsikas, Dimitrios
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 19
  • [33] Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: The putative role of asymmetric dimethylarginine (ADMA)
    Siervo, M.
    Corander, M.
    Stranges, S.
    Bluck, L.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2011, 21 (01) : 1 - 10
  • [34] Asymmetric dimethylarginine (ADMA) as a predictor of depression
    Oglodek, E.
    Just, M. J.
    Mos, D. M.
    Just, K.
    Fraszczak, M.
    Araszkiewicz, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S468 - U302
  • [35] Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy
    Beltowski, Jerzy
    Kedra, Anna
    PHARMACOLOGICAL REPORTS, 2006, 58 (02) : 159 - 178
  • [36] The synthesis and metabolism of asymmetric dimethylarginine (ADMA)
    James M. Leiper
    Patrick Vallance
    European Journal of Clinical Pharmacology, 2006, 62 : 33 - 38
  • [37] ASYMMETRIC DIMETHYLARGININE (ADMA) IN ENDOCRINE DISEASES
    Altinova, Alev Eroglu
    Arslan, Metin
    MARMARA MEDICAL JOURNAL, 2009, 22 (01): : 80 - 84
  • [38] The synthesis and metabolism of asymmetric dimethylarginine (ADMA)
    Leiper, JM
    Vallance, P
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (Suppl 1) : 33 - 38
  • [39] Asymmetric dimethylarginine (ADMA) as a predictor of depression
    Oglodek, E.
    Just, M. J.
    Mos, D. M.
    Just, K.
    Fraszczak, M.
    Araszkiewicz, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26
  • [40] The impact of ADMA (asymmetric dimethylarginine) on diabetes
    Galal, O.
    Verspohl, E. J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 36 - 36
12345